Abstract
Graft-versus-host disease (GVHD) in its acute (aGVHD) and chronic (cGVHD) form remains one of the most serious complications of allogeneic haematopoietic stem cell transplantation (allo-HSCT). There are several risk factors known to be associated with GVHD development. Some reports suggest that certain human leukocyte antigen (HLA) variants may influence the incidence of GVHD. The aim of our study was to analyse possible association between individual HLA alleles and the occurrence of aGVHD and cGVHD in patients following allo-HSCT from HLA-identical sibling donors. We have retrospectively reviewed medical records of 96 patients who received a transplant in the years 1994–2008. Cumulative incidence of acute GVHD was 31.3% and that of chronic GVHD was 26.0%. Recipients carrying the HLA-A*01, -DRB1*03 and -DQB1*03 alleles showed a statistically significantly lower incidence of aGVHD. Furthermore, the HLA-DQB1*06 allele was associated with a higher incidence of cGVHD. Each of these alleles was confirmed by logistic regression analysis as an independent factor with impact on GVHD development. Our results support findings of authors showing an association between certain HLA variants and GVHD appearance. However, other authors assume that there is no convincing evidence for such an association. Therefore, when taking into account limitations of our study design and the significant inconsistency in the results of the previous reports, a careful approach in judgement is required. To conclude, in our view, the prognostic value of individual HLA variants for GVHD development in a setting of HLA-identical allo-HSCT does not seem to be of great clinical relevance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- aGVHD:
-
Acute graft-versus-host disease
- allo-HSCT:
-
Allogeneic haematopoietic stem cell transplantation
- cGVHD:
-
Chronic graft-versus-host disease
- CI:
-
Confidence interval
- CsA:
-
Cyclosporin A
- HLA:
-
Human leukocyte antigens
- HSCT:
-
Haematopoietic stem cell transplantation
- miHA:
-
Minor histocompatibility antigens
- MTX:
-
Methotrexate
References
Billingham RE (1966) The biology of graft-versus-host reactions. Harvey Lect 62:21–78
Bradley BA (1991) The role of HLA matching in transplantation. Immunol Lett 29(1–2):55–59
Cardozo DM, Lieber SR, Marques SB, Aranha FJ, Vigorito AC, Souza CA, Visentainer JE (2012) Association between human leukocyte antigens and graft-versus-host disease occurrence after allogenic hematopoietic stem cell transplantation. Sao Paulo Med J 130(4):219–224
Clark RE, Hermans J, Madrigal A, Nachbaur D, Kropshofer G, Gratwohl A, Apperley J, Niederwieser D (2001) HLA-A3 increases and HLA-DR1 decreases the risk of acute graft-versus-host disease after HLA-matched sibling bone marrow transplantation for chronic myelogenous leukaemia. Br J Haematol 114(1):36–41. https://doi.org/10.1046/j.1365-2141.2001.02897
Couriel D, Caldera H, Champlin R, Komanduri K (2004) Acute graft-versus-host disease: pathophysiology, clinical manifestations, and management. Cancer 101(9):1936–1946. https://doi.org/10.1002/cncr.20613
Dickinson AM, Charron D (2005) Non-HLA immunogenetics in hematopoietic stem cell transplantation. Curr Opin Immunol 17(5):517–525. https://doi.org/10.1016/j.coi.2005.07.017
Dickinson AM, Norden J (2015) Non-HLA genomics: does it have a role in predicting haematopoietic stem cell transplantation outcome? Int J Immunogenet 42(4):229–238. https://doi.org/10.1111/iji.12202
Espinoza JL, Takami A, Nakata K, Onizuka M, Kawase T, Akiyama H, Miyamura K, Morishima Y, Fukuda T, Kodera Y, Nakao S (2011) A genetic variant in the IL-17 promoter is functionally associated with acute graft-versus-host disease after unrelated bone marrow transplantation. PLoS One 6(10):e26229. https://doi.org/10.1371/journal.pone.0026229
Ferrara JL, Deeg HJ (1991) Graft-versus-host disease. N Engl J Med 324(10):667–674. https://doi.org/10.1056/nejm199103073241005
Ferrara JL, Levine JE, Reddy P, Holler E (2009) Graft-versus-host disease. Lancet 373(9674):1550–1561. https://doi.org/10.1016/s0140-6736(09)60237-3
Flowers ME, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW, Pereira SE, Nash RA, Mielcarek M, Fero ML, Warren EH, Sanders JE, Storb RF, Appelbaum FR, Storer BE, Martin PJ (2011) Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 117(11):3214–3219. https://doi.org/10.1182/blood-2010-08-302109
Ghavamzadeh A, Alimoghaddam K, Behrouzan O, Bahar B, Jahani M, Sajadi S-A, Mohyeddin M (2002) HLA and risk of acute graft versus host disease in allogeneic bone marrow transplantation from an HLA-identical sibling. Archives of Iranian Medicine 5(1):16–20
Ghavamzadeh A, Alimoghaddam K, Jalili M, Mousavi SA, Bahar B, Kasaeian A, Hamidieh AA, Behfar M, Vaezi M, Jalali A, Jahani M (2016) Peripheral blood versus bone marrow transplant in patients with aplastic anemia, an unresolved issue. Bone Marrow Transplant 51(12):1628–1630. https://doi.org/10.1038/bmt.2016.235
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA, Lerner KG, Thomas ED (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18(4):295–304. https://doi.org/10.1097/00007890-197410000-00001
Gratwohl A, Brand R, Apperley J, Biezen Av A, Bandini G, Devergie A, Schattenberg A, Frassoni F, Guglielmi C, Iacobelli S, Michallet M, Kolb HJ, Ruutu T, Niederwieser D, Marrow T, Chronic Leukemia Working Party of the European Group for, B (2002) Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood 100(12):3877–3886. https://doi.org/10.1182/blood.V100.12.3877
Ichiki Y, Bowlus CL, Shimoda S, Ishibashi H, Vierling JM, Gershwin ME (2006) T cell immunity and graft-versus-host disease (GVHD). Autoimmun Rev 5(1):1–9. https://doi.org/10.1016/j.autrev.2005.02.006
IMGT/HLA Database – International ImMunoGeneTics information system/Humane Leukozyten Antigene Database https://www.ebi.ac.uk/ipd/imgt/hla/. Accessed 22 August 2019
Kim HJ, Park SJ, Im HW, Kim DW, Min WS, Kim HK, Kim WI, Kim KS, Kim CC (2002) The association of HLA antigen and GVHD in allogeneic hemopoietic stem cell transplantation with histocompatible sibling donor: a single-center experience in Korea. Int J Hematol 76(3):267–271
Martin PJ, Gooley T, Anasetti C, Petersdorf EW, Hansen JA (1998) HLAs and risk of acute graft-vs.-host disease after marrow transplantation from an HLA-identical sibling. Biol Blood Marrow Transplant 4(3):128–133. https://doi.org/10.1053/bbmt.1998.v4.pm9923410
Mohyeddin Bonab M, Alimoghaddam K, Vatandoust S, Forouzia F, Jahani M, Ghavamzadeh A (2004) Are HLA antigens a risk factor for acute GVHD in thalassemic patients receiving HLA-identical stem cell transplantation? Transplant Proc 36(10):3190–3193. https://doi.org/10.1016/j.transproceed.2004.10.088
Munakata W, Sawada T, Kobayashi T, Kakihana K, Yamashita T, Ohashi K, Onozawa Y, Sakamaki H, Akiyama H (2011) Mortality and medical morbidity beyond 2 years after allogeneic hematopoietic stem cell transplantation: experience at a single institution. Int J Hematol 93(4):517–522. https://doi.org/10.1007/s12185-011-0811-1
Na KS, Yoo YS, Mok JW, Lee JW, Joo CK (2015) Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 50(11):1459–1464. https://doi.org/10.1038/bmt.2015.187
Niederwieser D, Grassegger A, Aubock J, Herold M, Nachbaur D, Rosenmayr A, Gachter A, Nussbaumer W, Gaggl S, Ritter M et al (1993) Correlation of minor histocompatibility antigen-specific cytotoxic T lymphocytes with graft-versus-host disease status and analyses of tissue distribution of their target antigens. Blood 81(8):2200–2208
Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39(5):225–235
Perreault C, Decary F, Brochu S, Gyger M, Belanger R, Roy D (1990) Minor histocompatibility antigens. Blood 76(7):1269–1280
Remberger M, Persson U, Hauzenberger D, Ringden O (2002) An association between human leucocyte antigen alleles and acute and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Br J Haematol 119(3):751–759. https://doi.org/10.1046/j.1365-2141.2002.03924
Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Storb R, Thomas ED (1980) Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 69(2):204–217. https://doi.org/10.1016/0002-9343(80)90380-0
Smyth LA, Witt CS, Christiansen FT, Herrmann RP, Hollingsworth PN, Townend DC, Edward E, Dawkins RL (1993) The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 12(4):351–355
Storb R, Prentice RL, Thomas ED, Appelbaum FR, Deeg HJ, Doney K, Fefer A, Goodell BW, Mickelson E, Stewart P et al (1983a) Factors associated with graft rejection after HLA-identical marrow transplantation for aplastic anaemia. Br J Haematol 55(4):573–585. https://doi.org/10.1111/j.1365-2141.1983.tb02839
Storb R, Prentice RL, Hansen JA, Thomas ED (1983b) Association between HLA-B antigens and acute graft-versus-host disease. Lancet 2(8354):816–819. https://doi.org/10.1016/s0140-6736(83)90737-7
Tiercy JM (2016) How to select the best available related or unrelated donor of hematopoietic stem cells? Haematologica 101(6):680–687. https://doi.org/10.3324/haematol.2015.141119
Weisdorf D, Hakke R, Blazar B, Miller W, McGlave P, Ramsay N, Kersey J, Filipovich A (1991) Risk factors for acute graft-versus-host disease in histocompatible donor bone marrow transplantation. Transplantation 51(6):1197–1203. https://doi.org/10.1097/00007890-199106000-00010
Acknowledgments
All subjects are gratefully acknowledged for their participation in this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Data collection and all investigations were carried out in accordance with the principles of the Declaration of Helsinki and the study has been approved by the Institutional Ethic Committee.
Conflict of interest
The authors declare no potential conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Shawkatová, I., Bojtárová, E., Kováčová, M. et al. Individual HLA alleles and risk of graft-versus-host disease after haematopoietic stem cell transplantation from HLA-identical siblings. Biologia 75, 2045–2052 (2020). https://doi.org/10.2478/s11756-020-00510-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.2478/s11756-020-00510-1